Baldanti Annmarie MD New Rochelle, NY - 10801

Baldanti Annmarie MD is categorized under Internal Medicine Practitioners in New Rochelle, NY and active since 2002.

Baldanti Annmarie MD was established in 2002, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Annmarie Baldanti at the company’s single location by writing to 838 Pelhamdale Avenue, New Rochelle, New York NY 10801 or by phoning (914) 632-2030. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Baldanti Annmarie MD
Contact Person: Annmarie Baldanti
Address: 838 Pelhamdale Avenue, New Rochelle, New York 10801
Phone Number: (914) 632-2030
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Baldanti Annmarie MD was started in 2002 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Annmarie Baldanti for inquiries that concern Baldanti Annmarie MD by calling the company number (914) 632-2030, as your correspondence is most welcome. Additionally, the physical location of the single location of Baldanti Annmarie MD can be found at the coordinates 40.925619,-73.804851 as well as the street address 838 Pelhamdale Avenue in New Rochelle, New York 10801.

For its online presence, you may visit Baldanti Annmarie MD’s website at and engage with its social media outlets through on Twitter and on Facebook.